Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
Rheumatol Int
; 42(10): 1797-1806, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35486197
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Biological Products
/
Antirheumatic Agents
/
Spondylarthritis
/
Latent Tuberculosis
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Rheumatol Int
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: